Baidu
map

肿瘤科指南

订阅

MedSci主页 / 所有栏目 / 肿瘤科指南

2018 ESMO临床实践指南：成人癌痛的管理

2018-07-23 欧洲肿瘤内科学会 Annals of Oncology.2018.29 (Supplement 4): iv149–i

成人癌痛

2018年，欧洲肿瘤内科学会(ESMO)发布了成人癌痛的管理指南，用以替代2012年版指南。癌症患者疼痛常见，尤其是在晚期癌症的患者当中。本文主要内容涉及成人癌痛的评估，疼痛治疗原则，以及各种类型疼痛的管理。

中文标题：

2018 ESMO临床实践指南：成人癌痛的管理

英文标题：

Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines

发布机构：

欧洲肿瘤内科学会

发布日期：

2018-07-23

简要介绍：

2018年，欧洲肿瘤内科学会(ESMO)发布了成人癌痛的管理指南，用以替代2012年版指南。癌症患者疼痛常见，尤其是在晚期癌症的患者当中。本文主要内容涉及成人癌痛的评估，疼痛治疗原则，以及各种类型疼痛的管理。 

拓展指南：与癌痛相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2018 ESMO临床实践指南：成人癌痛的管理)] GetToolGuiderByIdResponse(projectId=1, id=2ac2a1c0016212cd, title=2018 ESMO临床实践指南：成人癌痛的管理, enTitle=Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines, guiderFrom=Annals of Oncology.2018.29 (Supplement 4): iv149–i, authorId=null, author=, summary=2018年，欧洲肿瘤内科学会(ESMO)发布了成人癌痛的管理指南，用以替代2012年版指南。癌症患者疼痛常见，尤其是在晚期癌症的患者当中。本文主要内容涉及成人癌痛的评估，疼痛治疗原则，以及各种类型疼痛的管理。 , cover=, journalId=null, articlesId=null, associationId=14, associationName=欧洲肿瘤内科学会, associationIntro=欧洲肿瘤内科学会（ESMO，European Society for Medical Oncology )是1975年成立的非盈利组织，是欧洲领先的专业组织，致力于提高肿瘤内科的专业性，推进癌症治疗和护理的多学科诊疗方法。, copyright=0, guiderPublishedTime=Mon Jul 23 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<div>2018年，欧洲肿瘤内科学会(ESMO)发布了成人癌痛的管理指南，用以替代2012年版指南。癌症患者疼痛常见，尤其是在晚期癌症的患者当中。本文主要内容涉及成人癌痛的评估，疼痛治疗原则，以及各种类型疼痛的管理。 </div> <div><br> </div>拓展指南：<strong>与<font color=red>癌痛</font>相关指南：</strong><br><ul><li><a href="//m.capotfarm.com/guideline/show_article.do?id=37e281c0015ae97a" title="癌痛患者护理指引专家共识（2017年版）" target=_blank>癌痛患者护理指引专家共识（2017年版）</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=537241c00150366a" title="难治性癌痛专家共识（2017年版）" target=_blank>难治性癌痛专家共识（2017年版）</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=b7d8b1c001a362bf" title="NCCN临床实践指南：成人癌痛（2017.V2）" target=_blank>NCCN临床实践指南：成人癌痛（2017.V2）</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=6aa261c001a030b2" title="NCCN临床实践指南：成人癌痛（2017.V1）" target=_blank>NCCN临床实践指南：成人癌痛（2017.V1）</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=efd991c001a028b8" title="2017 拉丁美洲指南：癌痛管理" target=_blank>2017 拉丁美洲指南：癌痛管理</a></li> 更多信息请点击：<a href="//m.capotfarm.com/guideline/list.do?q=%E7%99%8C%E7%97%9B" target=_blank>有关癌痛更多指南</a></ul>, tagList=[TagDto(tagId=78452, tagName=成人癌痛)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=2, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=7182, appHits=433, showAppHits=6, pcHits=4771, showPcHits=3292, likes=118, shares=20, comments=9, approvalStatus=1, publishedTime=Sat Jul 28 23:52:51 CST 2018, publishedTimeString=2018-07-23, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sat Jul 28 23:52:51 CST 2018, updatedBy=null, updatedName=null, updatedTime=Fri Jan 05 13:06:53 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2018 ESMO临床实践指南：成人癌痛的管理)])
2018 ESMO临床实践指南：成人癌痛的管理
下载请点击：
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=346777, encodeId=d306346e7733, content=谢谢分享，学习了，感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8e425737, createdName=tw007007, createdTime=Wed Sep 26 16:27:28 CST 2018, time=2018-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=336718, encodeId=6558336e18a1, content=癌痛的治疗。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/16/3b24606172648eea459125cb74754afe.jpg, createdBy=6c022216608, createdName=liumin1987, createdTime=Mon Aug 06 00:19:30 CST 2018, time=2018-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=335124, encodeId=f8e73351245c, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/f3d88083d8829740786bed95c22464d1/e325f3af93bb747a620d16c209094d69.jpg, createdBy=9efb2014947, createdName=小小小麦兜, createdTime=Mon Jul 30 13:36:15 CST 2018, time=2018-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=334904, encodeId=fdd43349043a, content=学习啦，不错了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b2c1627329, createdName=owlhealth, createdTime=Sun Jul 29 12:01:12 CST 2018, time=2018-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=334866, encodeId=ac9b3348662e, content=学习了受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Sun Jul 29 09:14:06 CST 2018, time=2018-07-29, status=1, ipAttribution=)]
    2018-09-26 tw007007

    谢谢分享，学习了，感谢

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=346777, encodeId=d306346e7733, content=谢谢分享，学习了，感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8e425737, createdName=tw007007, createdTime=Wed Sep 26 16:27:28 CST 2018, time=2018-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=336718, encodeId=6558336e18a1, content=癌痛的治疗。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/16/3b24606172648eea459125cb74754afe.jpg, createdBy=6c022216608, createdName=liumin1987, createdTime=Mon Aug 06 00:19:30 CST 2018, time=2018-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=335124, encodeId=f8e73351245c, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/f3d88083d8829740786bed95c22464d1/e325f3af93bb747a620d16c209094d69.jpg, createdBy=9efb2014947, createdName=小小小麦兜, createdTime=Mon Jul 30 13:36:15 CST 2018, time=2018-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=334904, encodeId=fdd43349043a, content=学习啦，不错了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b2c1627329, createdName=owlhealth, createdTime=Sun Jul 29 12:01:12 CST 2018, time=2018-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=334866, encodeId=ac9b3348662e, content=学习了受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Sun Jul 29 09:14:06 CST 2018, time=2018-07-29, status=1, ipAttribution=)]
    2018-08-06 liumin1987

    癌痛的治疗。

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=346777, encodeId=d306346e7733, content=谢谢分享，学习了，感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8e425737, createdName=tw007007, createdTime=Wed Sep 26 16:27:28 CST 2018, time=2018-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=336718, encodeId=6558336e18a1, content=癌痛的治疗。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/16/3b24606172648eea459125cb74754afe.jpg, createdBy=6c022216608, createdName=liumin1987, createdTime=Mon Aug 06 00:19:30 CST 2018, time=2018-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=335124, encodeId=f8e73351245c, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/f3d88083d8829740786bed95c22464d1/e325f3af93bb747a620d16c209094d69.jpg, createdBy=9efb2014947, createdName=小小小麦兜, createdTime=Mon Jul 30 13:36:15 CST 2018, time=2018-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=334904, encodeId=fdd43349043a, content=学习啦，不错了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b2c1627329, createdName=owlhealth, createdTime=Sun Jul 29 12:01:12 CST 2018, time=2018-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=334866, encodeId=ac9b3348662e, content=学习了受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Sun Jul 29 09:14:06 CST 2018, time=2018-07-29, status=1, ipAttribution=)]
    2018-07-30 小小小麦兜

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=346777, encodeId=d306346e7733, content=谢谢分享，学习了，感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8e425737, createdName=tw007007, createdTime=Wed Sep 26 16:27:28 CST 2018, time=2018-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=336718, encodeId=6558336e18a1, content=癌痛的治疗。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/16/3b24606172648eea459125cb74754afe.jpg, createdBy=6c022216608, createdName=liumin1987, createdTime=Mon Aug 06 00:19:30 CST 2018, time=2018-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=335124, encodeId=f8e73351245c, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/f3d88083d8829740786bed95c22464d1/e325f3af93bb747a620d16c209094d69.jpg, createdBy=9efb2014947, createdName=小小小麦兜, createdTime=Mon Jul 30 13:36:15 CST 2018, time=2018-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=334904, encodeId=fdd43349043a, content=学习啦，不错了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b2c1627329, createdName=owlhealth, createdTime=Sun Jul 29 12:01:12 CST 2018, time=2018-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=334866, encodeId=ac9b3348662e, content=学习了受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Sun Jul 29 09:14:06 CST 2018, time=2018-07-29, status=1, ipAttribution=)]
    2018-07-29 owlhealth

    学习啦，不错了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=346777, encodeId=d306346e7733, content=谢谢分享，学习了，感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8e425737, createdName=tw007007, createdTime=Wed Sep 26 16:27:28 CST 2018, time=2018-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=336718, encodeId=6558336e18a1, content=癌痛的治疗。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/16/3b24606172648eea459125cb74754afe.jpg, createdBy=6c022216608, createdName=liumin1987, createdTime=Mon Aug 06 00:19:30 CST 2018, time=2018-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=335124, encodeId=f8e73351245c, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/f3d88083d8829740786bed95c22464d1/e325f3af93bb747a620d16c209094d69.jpg, createdBy=9efb2014947, createdName=小小小麦兜, createdTime=Mon Jul 30 13:36:15 CST 2018, time=2018-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=334904, encodeId=fdd43349043a, content=学习啦，不错了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b2c1627329, createdName=owlhealth, createdTime=Sun Jul 29 12:01:12 CST 2018, time=2018-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=334866, encodeId=ac9b3348662e, content=学习了受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Sun Jul 29 09:14:06 CST 2018, time=2018-07-29, status=1, ipAttribution=)]
    2018-07-29 131****1460

    学习了受益匪浅

    0

Baidu
map
Baidu
map
Baidu
map